UNCOMMON DENOMINATOR
Venture capitalNew York · Seed–Series A · 4 people tracked
Investment thesis
The firm targets consumer brands that resonate psychologically with audiences through authentic positioning and distinctive marketing. For software, it invests in SaaS solutions that demonstrably save costs or increase revenue for enterprise clients, avoiding middle-ground products. In frontier technology, it seeks innovations that rapidly bridge the gap between speculative futures and present-day viability. The firm emphasizes companies with concentrated expertise in key functional areas rather than relying solely on standard benchmarks.
Source: firm website, verified Jul 21, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 2 of 2 portfolio companiesDirect to Consumer ×2Biotech ×1Consumer ×1Healthtech ×1Longevity ×1Wellness & Fitness ×1
Investments · 2 tracked
founders shown can be your intro pathNOVOS is a longevity biotechnology company that develops science-validated supplement formulations and aging assessment tools designed to target the biological mechanisms of aging rather than disease symptoms. The company serves consumers seeking to extend healthspan through evidence-based products backed by clinical trials and mechanistic research.
BiotechDirect to ConsumerHealthtechLongevityWellness & Fitness<UNKNOWN>
Chris Mirabile(Founder & CEO)
Frequently asked questions
- What stage does UNCOMMON DENOMINATOR invest at?
- UNCOMMON DENOMINATOR invests at the Seed, Series A stages.
- What sectors does UNCOMMON DENOMINATOR focus on?
- UNCOMMON DENOMINATOR focuses on Consumer, Deep Tech, SaaS.
- Where is UNCOMMON DENOMINATOR located?
- UNCOMMON DENOMINATOR is headquartered in New York, US.
Similar investors
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Hyderabad Angels is a collective of experienced entrepreneurs, industrialists, and family offices founded in 2010 that provides mentorship, capital, and network access to early-stage founders. The organization invests in seed and pre-seed companies across sector-agnostic technology, healthcare, consumer, and other emerging sectors.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
An early-stage venture capital firm investing in technology founders building solutions across multiple sectors.
Octopus Ventures is a pan-European early-stage venture capital firm that invests from pre-seed through Series A and beyond, with pre-seed investments typically at £100k and later-stage investments starting at £1 million.